ATG5 and chronic myelogenous leukemia, BCR-ABL1 positive: Previously, it was reported that cell death in BCR-ABL-positive CML cells was significantly increased following either treatment with an autophagy inhibitor or the silencing of the autophagy genes ATG5 and ATG7.